Navigation Links
First clinical trials successfully completed on potent new hepatitis C drug
Date:9/3/2010

The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed.

Completion of the initial phase (phase 1a) of trials of INX-189, discovered and first prepared by researchers at Cardiff University's Welsh School of Pharmacy in 2008, means the chances of it becoming an approved medicine have significantly improved.

Approximately 170 million people worldwide are affected with Hepatitis C, which can lead to liver cancer, cirrhosis and death. It is the leading cause of liver transplantation in western countries. The current treatment involves two drugs ribavirin and interferon, which has to be given as an injection. Side effects are often severe and lead to patients failing to complete the treatment.

Professor Chris McGuigan of the Welsh School of Pharmacy, academic lead on the project, said: "This is still a very early stage of the trials process but none the less a significant development. Successfully completing phase 1a demonstrates that the drug is safe, with no drug-related side effects at all in a single dose of 100mg.

"The efficiency of drug release in this study has also confirmed that one single dose a day is most likely enough in treating the virus.

"We believe that INX-189 offers the possibility of more potency against Hepatitis, more rapid action in the liver, and fewer side effects than existing treatments."

In 2008, laboratory tests showed INX-189 killed 90 per cent of the virus at very low (nanomolar) concentration, making it the most potent compound of its kind developed to date.

US pharmaceutical company Inhibitex, which owns the licence to INX-189 and has been working with the Cardiff team, has announced it is looking forward to a second trial (phase 1b), which would evaluate the compound's effectiveness in Hepatitis C patients.

Cardiff University and Inhibitex filed a patent on INX-189 earlier
'/>"/>

Contact: Lowri Jones
joneslc3@cardiff.ac.uk
Cardiff University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Almost 1 in 3 First-Time Deliveries Now Via C-Section
2. For the first time, researchers identify and isolate adult mammary stem cells in mice
3. Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
4. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
5. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
6. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
7. Deaf, hard-of-hearing students perform first test of sign language by cell phone
8. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
9. Doctors hard to find for patients in Massachusetts first for-profit health plan
10. Scientists develop the first model for investigating the origins of testicular cancer in humans
11. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... -- Close friends have more influence on teens, alcohol ... study says. "We,ve known for a long ... individual alcohol use, but there are no common studies ... friend group,s influence on those decisions," Jonathon Beckmeyer, an ... said in a university news release. Beckmeyer analyzed ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, ... the new products are available at low rates up ... proud of the new emergency doors. The emergency door ... can choose from several colors. All of the products ... door release is not as easy as many people ...
(Date:11/23/2014)... show thanks to new and old customers, iFitDress.com has ... for weddings. Customers who need custom outfits can talk ... dress manufacturer, and it is among the ones which have ... long time. The CEO of this company says, "iFitDress.com is ... buy not only a beautiful dress, but also a piece ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
(Date:11/23/2014)... 23, 2014 Asher Milgrom, is ... & Wellness was recently featured on International ... president and CEO of American Medical Aesthetics & Wellness, ... received a full scholarship to attend an M.D./Ph.D program ... at the University of Chicago, where his field of ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4
... FRIDAY, March 25 (HealthDay News) -- Even very young ... negative emotions toward them, researchers confirm. The new ... harmless, but stress-inducing, situations, such as causing them to ... saliva samples were taken from the children to measure ...
... FRIDAY, March 25 (HealthDay News) -- Most people want to ... through with healthy lifestyle habits, finds a new survey. ... found that 93.3 percent of respondents believe they are more ... said their doctor was more responsible and 2.3 percent didn,t ...
... Reporter , FRIDAY, March 25 (HealthDay News) -- Teen superstar Nick ... ago his body was wasting away. Even at 13, Jonas knew ... something was type 1 diabetes, and though it,s a disease Jonas ... because he spends a lot of time every day taking care ...
... Food and Drug Administration today approved the use of ipilimumab ... the first drug approved for metastatic, or advanced, melanoma is ... a new class of drugs that has been shown to ... a fatal disease, and hopefully, this will lead to the ...
... York, NY, Mar. 25, 2011 The U.S. Food and ... treatment for advanced melanoma, the deadliest and most difficult-to-treat form ... is the first treatment of any kind ever shown in ... improve overall survival in patients with metastatic melanoma who no ...
... News) -- Seniors who suffer elder abuse are more likely ... and to abuse drugs or alcohol, new research indicates. ... Chicago-area trauma units and compared 41 cases of elder abuse ... group) who were treated between 1999 and 2006. The ...
Cached Medicine News:Health News:Study Highlights How Moms' Depression, Anger Stresses Kids 2Health News:Nick Jonas Lives Large, Despite Diabetes 2Health News:Nick Jonas Lives Large, Despite Diabetes 3Health News:FDA approves new drug for advanced melanoma 2Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 2Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 3Health News:FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma 4Health News:Alcohol May Play Dual Role in Some Cases of Elder Abuse 2
(Date:11/23/2014)... Nov. 23, 2014  Aurobindo Pharma USA ... Capsules, USP 300 mg 100-count bottles to the consumer ... some empty capsules. Empty capsules could result ... consequences that could range from no effect, short term ... epilepticus (long period seizures) that could be life-threatening. Aurobindo ...
(Date:11/22/2014)... 2014   Long Beach dentist , Dr. Rassouli, is ... gold standard in tooth replacement because they offer the closest ... to restore and preserve smiles and improve overall dental health. ... tooth or as a part of a smile makeover or ... of a smile. The loss of a tooth ...
(Date:11/22/2014)... 21, 2014 Many power shifts are ... influence of patients in the biopharmaceutical market is ... more than ever, understanding how to effectively acquire, ... is essential. According to recent ... companies spent about two-thirds of their patient-focused dollars ...
Breaking Medicine Technology:Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2
... of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® system, ... a 2011 Technology Pioneer. Through a rigorous screening process, ... from around the world that develop and apply the ... of making a critical impact on the future of ...
... The SCOOTER Store, the nation,s largest provider of ... of a new internal division focusing on Home Care ... power mobility business. The new Home Care ... and operate out of the national headquarters location of ...
Cached Medicine Technology:Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer 2Neuronetics Selected by World Economic Forum as 2011 Technology Pioneer 3The SCOOTER Store Creates Home Care Equipment Division 2The SCOOTER Store Creates Home Care Equipment Division 3
... a rapid qualitative test for detection of ... serum samples. It can be used as ... infarction and can be useful to assess ... non-cardiac angina (e.g. gastric pain, strained chest ...
...
...
...
Medicine Products: